ESCATEC creates new innovative solutions for mutual growth with customers at new flagship HQ
plus
Actualités sur Swiss
-
Langue:
Anglais
- Médias:
- Période:
- Période:Totale
- 14
Hermès at the Salon International de la Haute Horlogerie (SIHH) 2018
plus Hombrechtikon Systems Engineering AG
HSE-AG introduces modular, automated qPCR TubeSealer / New bead-based technology integrates into any workflow and reduces contamination risk
plusswissstaffing - Verband der Personaldienstleister der Schweiz
Swiss Staffingindex - Staff leasing sector closes up by 4.2 percent in 3rd quarter
Un documentplusEidgenössische Revisionsaufsichtsbehörde - RAB
FAOA concludes inspection regarding FIFA audit
Berne (ots) - The FAOA has inspected selected aspects regarding the audit of the annual financial statements and consolidated financial statements 2008 to 2014 of the Fédération Internationale de Football Association (FIFA). Numerous media reports provided clues to several suspected irregularities that might have happened in the FIFA entourage. It could not be excluded that these irregularities also had an impact on the ...
plus- 2
Neovii Pharmaceuticals AG announces new CEO
plus Zürcher Kantonalbank grows profit by 7% to CHF 420 million in the first half of 2017
Zürich (ots) - Zürcher Kantonalbank significantly increased its net profit to CHF 420 million in the first half of 2017, a rise of 7% compared to the same period of 2016. All income drivers contributed to this pleasing result. With a total capital ratio of 17.9%, Zürcher Kantonalbank has further ...
Un documentplusBertrand Jungo appointed new CEO of Admeira
plusswissstaffing - Verband der Personaldienstleister der Schweiz
Impressive 6.9% growth in the staff leasing industry in the 2nd quarter
plusJens Paul Berndt is the new Chief Technology Officer at Homegate AG
Zurich (ots) - Jens Paul Berndt (47), new Chief Technology Officer (CTO), is now consolidating the Homegate AG management team. Berndt assumes responsibility for technological development and operation of the leading Swiss real estate portal. He reports directly to CEO Axel Konjack. In the last 20 years, Jens Paul Berndt has become proficient in a broad range of areas in the digital and IT environment. Berndt previously ...
plusDebiopharm International SA and Arbor Pharmaceuticals, LLC Announce U.S. FDA Approval for Triptodur(TM), Triptorelin 6-month Formulation, in the Treatment of Central Precocious Puberty (CPP)
Lausanne, Switzerland and Atlanta, GA (ots) - Triptodur (TM), (triptorelin) for extended release injectable suspension, has been shown to arrest or reverse the clinical signs of puberty with once every six-month intramuscular injection (IM) dosing for children with CPP Approval brings new CPP treatment formulation ...
plusGenePOC Announces an Exclusive Distribution Agreement with Cardinal Health covering the US market
Québec, Canada (ots) - GenePOC announces the signing of an exclusive distribution agreement with Cardinal Health to become its commercial partner in the United States. GenePOC, Inc. (GenePOC), a member of the Debiopharm Group, is proud to announce that it has signed an exclusive distribution agreement with Cardinal ...
plus- 2
A new generation of anti-doping security bottles
plus Zürcher Kantonalbank successfully launches Additional Tier 1 bond
Zurich (ots) - Zürcher Kantonalbank issues 2.125% Additional Tier 1 bond with a notional amount of CHF 750 million as of 30 June 2017. Zürcher Kantonalbank has issued today a new Additional Tier 1 (AT1) bond with contingent write-down with a notional amount of CHF 750 million and a coupon of 2.125%, meeting a strong investor demand. The new AT1 bond ...
Un documentplusDebiopharm International SA Announces Completion of Enrollment in Phase I/II Clinical Trial with Debio 1143 in SCCHN
Lausanne (ots) - A total of 96 patients randomized in France and Switzerland. Results expected in Q1 2019. Debiopharm International SA (Debiopharm - www.debiopharm.com), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, today announced the completion of enrollment in dose finding and ...
plusGenePOC announces FDA clearance for revogene(TM) instrument and its GBS LB test
Québec, Canada and Lausanne, Switzerland (ots) - GenePOC announces it received 510(k) clearance from the US Food and Drug Administration to market its first molecular assay to detect Group B Streptococcus and for the revogene molecular diagnostics instrument. GenePOC, Inc. (GenePOC) a member of the Debiopharm Group is pleased to announce that it has received FDA ...
plusswissstaffing - Verband der Personaldienstleister der Schweiz
2New industry barometer: staff leasing industry up 1.9% in 2016
plusDebiopharm International SA Enters the Field of Antibody-Drug Conjugates Through Acquisition of Phase II Asset from ImmunoGen
Lausanne, Switzerland and Waltham, Mass. (ots) - Transaction adds innovative clinical-stage program to expanding Debiopharm portfolio and broadens its clinical development expertise Divestiture aligns with ImmunoGen's focus on strategic growth initiatives and generates near-term value Debiopharm International SA ...
plusZürcher Kantonalbank redeems Additional Tier 1 bond and plans to issue new Additional Tier 1 bond
Zurich (ots) - Zürcher Kantonalbank is calling the Additional Tier 1 bond with a notional amount of CHF 590 million as of 30 June 2017 and intends to issue a new Additional Tier 1 bond. Zürcher Kantonalbank is today announcing the redemption of its ...
Un documentplusBC Platforms Closes USD $10 million Series B Financing led by Debiopharm and Tesi to accelerate knowledge platform development
Basel, Switzerland, Lausanne, Switzerland and Helsinki, Finland (ots) - Leading Big Data company developing platform with clinical and genomic data from 5 million subjects, to transform drug development and bring clinical benefits to patients. BC Platforms, a world leader in genomic data management solutions, today ...
plus- 2
Symetis and Boston Scientific reach USD 435 million purchase agreement
plus Debiopharm Innovation Fund: the New Name and Investment Strategy of Debiopharm Diagnostics
Lausanne (ots) - Change in name reflects new strategy to invest in smart data, therapeutics and diagnostics Debiopharm Diagnostics SA, the strategic investment fund of Debiopharm Group(TM) (www.debiopharm.com), announced its new strategy and the change of name to Debiopharm Innovation Fund SA effective today. With the aim of speeding up innovations that radically ...
plusZürcher Kantonalbank delivers record income of CHF 2.3 billion and increases group operating profit to CHF 761 million
Zurich (ots) - Zürcher Kantonalbank grew its group operating profit by 5% to CHF 761 million in 2016. Higher commission and fee income and a strong performance in trading were the main drivers of this result. The distribution to the canton and ...
2 DocumentsplusComputershare completes acquisition of Swiss SIX SAG AG
Olten (ots) - Computershare Limited (ASX: CPU) has completed the acquisition of Swiss SIX SAG AG ("SAG", renamed with immediate effect to Computershare Schweiz AG) from SIX Securities Services AG. With this acquisition, Computershare, the globe's leading provider of registrar services is extending its market presence in Continental Europe. With the completed acquisition Computershare has taken over SIX SAG AG (renamed ...
plusSale of Swissgrid convertible bond / BKW is selling its convertible bond to Credit Suisse
plusBKW expands its wind power portfolio / Acquisition of four wind farms in France
plusBKW AG - Swissgrid: Revaluation of BKW's share of the transmission grid
plusAcquisition of Alpiq's shares in Swissgrid: BKW and SIRESO reach agreement on their share in Swissgrid
plusSustainability / Emmi switches to 100 % renewable hydroelectricity from BKW
plus2016 half-year results / BKW increases revenue and profit
plus
Précédent9101112131415161718Suivant